Assessment of long-term stored specimens in the Siriraj Hospital colorectal cancer biobank for RNA sequencing and profiling
Author:
Suwatthanarak Thanawat1, Acharayothin Onchira2, Thanormjit Kullanist1, Chaiboonchoe Amphun3, Suwatthanarak Tharathorn2, Niyomchan Apichaya4, Pithukpakorn Manop5, Tanjak Pariyada1, Chinswangwatanakul Vitoon2
Affiliation:
1. Siriraj Cancer Center, Faculty of Medicine Siriraj Hospital , Mahidol University , Bangkok , Thailand 2. Department of Surgery, Faculty of Medicine Siriraj Hospital , Mahidol University , Bangkok , Thailand 3. Siriraj Center of Systems Pharmacy, Faculty of Medicine Siriraj Hospital , Mahidol University , Bangkok , Thailand 4. Department of Anatomy, Faculty of Medicine Siriraj Hospital , Mahidol University , Bangkok , Thailand 5. Department of Medicine, Faculty of Medicine Siriraj Hospital , Mahidol University , Bangkok , Thailand
Abstract
Abstract
Objectives
Biobanks play an important role in advancing cancer research, yet concerns persist regarding the molecular integrity of long-term stored samples. This study assessed fresh frozen (FF) tissues and formalin-fixed paraffin-embedded (FFPE) tissues from the Siriraj Hospital colorectal cancer (CRC) biobank collected during two distinct periods (2011–2012 and 2020–2021).
Methods
In 2022, FF and FFPE primary cancer tissues from 75 CRC patients were evaluated. RNA sequencing (RNA-Seq) analyzed comprehensive gene expression profiles in FF tissues preserved at −80 °C, while nCounter profiling elucidated cancer-specific RNA transcripts in FFPE tissues stored at ambient temperature. Comparative analyses were conducted between specimens from 2011 to 2012 and 2020–2021.
Results
The FF tissues stored for approximately 10.5 years were well-suited for RNA-Seq compared to the intact tissues preserved for 1.5 years. Despite consistencies in RNA quantity, RNA integrity, amount of sequencing reads, and CRC gene signature, gene enrichment analysis revealed the decreased ribosome biogenesis, spliceosome and antifolate resistance pathways in the 2011–2012 group. Moreover, the FFPE tissues also showed no alteration in RNA quantity between the two periods, and the nCounter profiling demonstrated comparable CRC-specific gene counts in spite of the significant reduction of raw counts in the 2011–2012 group.
Conclusions
We report that FF tissues from CRC patients, stored for 10 years, are viable for whole transcriptome RNA-Seq, despite altered pathways such as ribosome biogenesis, spliceosome, and antifolate resistance. Moreover, 10-year-stored FFPE CRC tissues remain suitable for specific RNA profiling using the nCounter pan-cancer panel, despite a significant reduction in raw counts. These findings underscore the enduring contribution of biobanks to molecular research, highlighting their value a decade post-collection.
Funder
Foundation for Cancer Care, Siriraj Hospital Health Systems Research Institute
Publisher
Walter de Gruyter GmbH
Reference22 articles.
1. Hossain, MS, Karuniawati, H, Jairoun, AA, Urbi, Z, Ooi, J, John, A, et al.. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers 2022;14:1732. https://doi.org/10.3390/cancers14071732. 2. Coppola, L, Cianflone, A, Grimaldi, AM, Incoronato, M, Bevilacqua, P, Messina, F, et al.. Biobanking in health care: evolution and future directions. J Transl Med 2019;17:172. https://doi.org/10.1186/s12967-019-1922-3. 3. Annaratone, L, De Palma, G, Bonizzi, G, Sapino, A, Botti, G, Berrino, E, et al.. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch 2021;479:233–46. https://doi.org/10.1007/s00428-021-03151-0. 4. Lewis, C, McQuaid, S, Hamilton, PW, Salto-Tellez, M, McArt, D, James, JA. Building a ’Repository of Science’: the importance of integrating biobanks within molecular pathology programmes. Eur J Cancer 2016;67:191–9. https://doi.org/10.1016/j.ejca.2016.08.009. 5. Alsagaby, SA. Investigating the impact of RNA integrity variation on the transcriptome of human leukemic cells. 3 Biotech 2022;12:160. https://doi.org/10.1007/s13205-022-03223-1.
|
|